Arrayit’s CEO, Rene Schena, Chosen to Promote Economic Growth Center to Big Pharma and Biotech Businesses

Rene Schena, the CEO of Arrayit, a bio business leader in microarrays is the focus of a video documentary by the City of Sunnyvale to attract businesses relocating to the San Francisco Bay Area

1

Arrayit’s CEO, Rene Schena, Chosen to Promote Economic Growth Center to Big Pharma and Biotech Businesses

Welcome visit Our WebSite:

http://www.arrayit.com

More Press Release

• Background on Arrayit’s CEO, Rene Schena, Chosen to Promote Economic Growth Center to...

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) December 6, 2011 --(Updated - February 2, 2012) With pharmaceutical companies like Pfizer Inc. investing in shifting operations to a few bioscience hotspots (Wall Street Journal, November 23, 2011), Sunnyvale, CA, in the heart of Silicon Valley, is betting that a testimonial by successful CEO Rene Schena of Arrayit Corporation, will seal the deal. Sunnyvale is currently home to Lockheed Martin, Yahoo, Network Appliance, Northrop Grumman Marine, Molecular Devices, Intuitive Surgical, St. Jude Medical, and research organizations such as the Parkinson’s Institute and NASA Ames Space Science Research Center. Google is opening a campus in Sunnyvale in 2012. Indeed, Sunnyvale was the #1 top rated City throughout North and South America for “Best Economic Potential” this year, according to Financial Times “American Cities of the Future 2011/12” report. Sunnyvale also topped the list of “25 Most Inventive Cities” in the nation with more patents per capita than any other as ranked by TheDailyBeast.com, a merger of the Daily Beast & Newsweek.

“Rene Schena, CEO of Arrayit Corporation, demonstrates leadership, determination and the ability to project success through a business with fantastic potential,” said the Sunnyvale Economic Development spokesperson. Arrayit provides products to researchers and institutions and OEM products for multi-billion dollar corporations around the world and in its own backyard of Sunnyvale. As CEO, Ms. Schena was rated #11th “Largest Woman Owned Business” in 2005 by the Silicon Valley Business Journal and as a private company, twice achieved status as the “Fastest Growing” Biotech Company in America by Inc. Magazine’s the Inc.500. Now publicly traded, Arrayit is benefiting from its credibility on the lab-bench, offering novel proprietary products manufactured in Sunnyvale in instrumentation, products and services for the life science, research and diagnostic industries. Under Rene Schena's stewardship, Arrayit's patented gene and protein printing technologies have the lead the microarray field since its inception. Arrayit's discoveries in microarray applications have now led the company beyond research tools and instrumentation into the clinical diagnostics arena as it continues to develop its OvaDx cancer diagnostic.

The video documentary produced by the City of Sunnyvale will be available mid February 2012.

Schena’s vision of the future is cutting edge – in both Bio Business and CleanTech. As early as 2002 she invested in the development of a proprietary clean diesel technology. Now this pure fuel is being fleet tested by the City of Sunnyvale in municipal trucks. It’s no wonder Schena is held up as an example of success - a determined, successful CEO running a forward thinking company with an exciting future in the #1 City for “Best Economic Potential”.


About Arrayit
Arrayit Corporation, headquartered in Sunnyvale, California, leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. Please visit www.arrayit.com for more information.

Safe Harbor Statement
We have identified forward-looking statements by using words such as "expect", "believe", and "should". Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's Form 10-KA for the fiscal year ended December 31, 2010 and Form 10-QA for the fiscal quarter ended September 30, 2011.

More information can be found online at http://www.arrayit.com

Best small cap companies     bio business     Biotech     CEO of Arrayit     example     microarray     pharma relocation     Rene Schena